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and CABG. We analysed the following data: age,
sex, hypertension, hyperlipidemia, diabetes,
carotid bruit, the presence of peripheral arterial
obliterative disease and their association with the
severity of carotid and coronary artery disease.
Results:  The prevalence of ICA stenosis over 50%
occurred in 16,1% of patients, the prevalence of
ICA stenosis over 70% was 6,4%. According to
risk factors we found statistical significance in
correlation between ICA stenosis over 50% (p <
0,0001), and also between ICA stenosis over 70%
(p < 0,002) with peripheral artery occlusive
disease. We did not find any statistical significance
in correlation of carotid artery stenosis with age,
sex, hypertension, hyperlipidemia and diabetes.
We found statistical significance in correlation for
coronary artery disease only with hyperlipidemia
(p < 0,029), other risk factors (age, sex,
hypertension, peripheral artery occlusive disease
and diabetes) did not correlate in statistical
significance with coronary artery disease.
Conclusions:  We determined the prevalence of
carotid artery disease in patients undergoing
CABG and/or VR. We analysed risk factors and
their association with carotid artery disease and
also with coronary artery disease.
Funding: none
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BENEFICIAL EFFECT OF PREINFARCTION ANGINA ON 
VENTRICULAR ARRHYTHMIAS IN PATIENTS 
AFTER PRIMARY ANGIOPLASTY 
E. Lykasova, Y. Pak, V. Todosiychuk,
V. Kuznetsov. Tyumen Cardiology Center, 
Tyumen, Russia 
Objective:  Preinfarction angina (PIA), which can
serve as a surrogate marker for ischemic
preconditioning, is associated with the better
clinical outcome in patients with acute myocardial
infarction (AMI). The antiarrhythmic effect of PIA
in patients treated with primary angioplasty (PA)
has not been investigated. The aim of this study
was to clarify the effect of PIA on ventricular
arrhythmias in patients after PA. Methods:  17
consecutive patients (15 male; aged 52,8 ± 2,5
years) with AMI after PA were prospectively
studied and divided into two groups: A (n=8) with
presence of PIA (defined as at least one brief
episode of angina occurred within 2-72 hours
before onset of AMI) and B (n=9) without PIA.
These groups were matched for baseline
characteristics. A numbers of isolated ventricular
premature beats (VBP), ventricular couplets (VC)
and non-sustained ventricular tachycardia (NSVT)
recorded on 24-hour Holter monitoring in the first
day of AMI were estimated. Results: Total
numbers of VPB, VC, NSVT were significantly
lower in group A than in group B (81,0±29,95 vs
379,44±117,83, ρ=0,023; 0,57±0,29 vs 50,0±31,8,
ρ=0,005; 2,28±1,79 vs 58,33±37,09, ρ=0,019
recpectively). Conclusions: PIA is associated with
decrease of ventricular arrhythmias in patients
after PA. This favorable effect of PIA may be
detected by 24-hour Holter monitoring in early
phase of AMI.
Funding: Tyumen Cardiology Centre, Tyumen,
Russia 
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THE MIAMI STUDY (MARKERS OF INFLAMMATION 
AND ATORVASTATIN EFFECT IN PREVIOUS 
MYOCARDIAL INFARCTION): RESULTS 
OF A PROSPECTIVE, MULTICENTER STUDY 
B. Porta1, D. Baldassarre2,3, M. Camera2,3,
M. Amato3, M. Arquati1, E. Tremoli2,3, M. 
Cortellaro1, F. Perego1. 1L. Sacco Hospital, 
Department of Clinical Sciences, Milan University, 
Milan, Italy, 2Department of Pharmacological 
Sciences, Milan University, Milan, Italy, 
3Cardiologico Monzino Center-IRCCS, Milan, Italy 
Objective:  MIAMI is a prospective multicenter
clinical study designed to investigate the
relationship between C-IMT progression and
changes in circulating markers of inflammation,
coagulation and endothelial dysfunction in patients
with stable CAD treated for two years with 20 mg/
day atorvastatin. Methods:  C-IMT, blood lipids
and soluble markers were measured at baseline, at
the 12th month and at the end of the study in
eighty-five patients. Results: Atorvastatin induced
C-IMT regression. Fibrinogen, TFPI-total,
sICAM-1, sE-selectin, IL-8 and vWF, but not hs-
CRP, IL-18, TFPI-free, sVCAM-1, IL-6, TNF-α
and sCD40L, decreased upon treatment. Changes
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in lipids did not correlate with C-IMT regression.
Changes in single soluble markers correlated
poorly with C-IMT regression, but strongly when
combined in relevant composite scores
(inflammation/coagulation-score, endothelial
activation-score, soluble markers-score and total-
score). Conclusions: In patients with stable CAD,
a moderate dose of atorvastatin was associated
with regression of C-IMT. This effect was
correlated with changes of inflammation,
thrombosis and endothelial dysfunction profiles.
Funding: Partial support by a grant from Pfizer-
Italia
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BIOCHEMICAL AND MECHANICAL PROPERTIES 
OF INTRALUMINAL THROMBUS FROM HUMAN 
ABDOMINAL AORTIC ANEURYSM 
R. Ballerio1, F. Boschetti2, R. Spirito1,
S. Bellosta3, A. De Francesco3, M. Canavesi3,
E. Di Martino4, E. Tremoli1,3, M. Camera1,3.
1Centro Cardiologico Monzino, Milan, Italy, 
2LaBS, Dept. Structural Eng, Politecnico di 
Milano, Milan, Italy, 3Department of 
Pharmacological Sciences, University of Milan, 
Milan, Italy, 4Inst. Complex Engineered Systems, 
Carnegie Mellon Univ., Pittsburgh, PA, USA 
Abdominal aortic aneurism (AAA) is often
associated with an intraluminal thrombus (ILT)
which is a source of matrix metalloproteinases
(MMP2 and MMP9) involved in aneurismal
rupture. Biomechanical considerations are
important to understand this process and to
improve the prediction of its occurrence. We
correlated MMP2 and MMP9 content with
permeability (k) and compression properties (E) of
the same ILT samples. ILTs from 12 patient
undergoing surgical AAA resection were
processed to obtain the luminal (L), medial (M)
and abluminal (AL) layers. Samples of each layer
were processed for immunoenzymatic and
zymography detection of MMP2 and MMP9,
compression/permeation determination, histology/
immunohistochemistry and Scanning Electron
Microscopy analysis (SEM). Expression of MMP9
was significantly higher in L (+625.9%±231)
compared to M (327.7%±140) and AL (100%) and
this was inversely correlated with the compression
properties of ILTs measured by elastic modulus
(EL=11.1±2.9; EM=19.4±12.4; EAL=23.4±17.0,
E=kPa). MMP9 activity followed the same pattern.
Conversely, MMP2 levels did not change within
the layers (average 26±4.2 ng/mg protein content).
SEM analysis showed a non-homogeneous
trabecular fibrin structure with smaller pores in L
and AL compared to M, consistent with the
measured values of permeability, lower in L and
AL compared to M (kL=0.03±0.02;
kM=0.04±0.04; kAL=0.04±0.02, k=mm4/N-s).
Our data show that the ILT is non homogeneous
and that its mechanical and biochemical properties
vary across the thickness, with the luminal layer
exhibiting the highest MMP9 content and the
lowest stiffness and permeability.
Funding: none
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HEAT SHOCK PROTEIN AND ANTIBODY RESPONSE 
TO CHLAMYDIA PNEUMONIAE IN CORONARY 
ATHEROTHROMBOSIS 
I. Burazor1, A Vojdani2, M Burazor1. 1Clinical 
Center-Cardiology, Nis, Serbia, 2Immunosciences 
Lab. Inc, Los Angeles, CA, USA 
Atherothrombosis might be caused by
autoimmune and infectious underlying
mechanisms. We aimed to investigated the
presence of antibodies against Chlamyidia
pneumoniae (Cp) and Cp heat shock protein 70
(HSP) in atherothrombosis. Patients and Results:
Study included 211 subjects of whom 111 were
patients with acute coronary syndromes and 100
were aged and sex matched controls: 50 from
Serbia and 50 from California. We measured anti
Cp HSP 70 antibodies and anti Cp IgG antibodies.
Total of 72% patients with ACS were positive on
anti Cp IgG antibodies, 40% of controls from
Serbia and 14% of controls from California.
Seropositivity to Cp HSP 70 IgG was detected in
31% of patients with ACS, 13% of controls from
Serbia. None of the subjects from California was
positive on anti Cp HSP 70 IgG. There was the
deference between anti Cp IgG antibodies
(p<0.001). Cp HSP 70 IgG antibodies where
higher in patient population then in controls
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